Form 4: TransDigm Group Director Robert Small Sells Shares in Multiple Transactions

Sentiment:

SEC Form 4 Filing


Robert Small, a director at TransDigm Group INC, reported the sale of common stock in multiple transactions on March 13th and 14th, 2025.

Summary

  • Robert Small, a director of TransDigm Group INC (TDG), filed a Form 4 detailing the sale of common stock.
  • The transactions occurred on March 13th and 14th, 2025.
  • Shares were sold indirectly through Stockbridge Partners LLC and Stockbridge Fund, L.P.
  • A total of 209 shares were sold on March 13th at a price of $1,335.2189 per share through Stockbridge Partners LLC.
  • An additional 791 shares were sold on March 13th at a price of $1,335.2189 per share through Stockbridge Fund, L.P..
  • On March 14th, 558 shares were sold at a weighted average price of $1,336.2317 through Stockbridge Partners LLC.
  • Also on March 14th, 2,742 shares were sold at a weighted average price of $1,336.2317 through Stockbridge Fund, L.P..
  • Further sales on March 14th included 288 shares at $1,340.85 through Stockbridge Partners LLC and 1,412 shares at $1,340.85 through Stockbridge Fund, L.P..
  • Finally, on March 14th, 682 shares were sold at $1,345.2428 through Stockbridge Partners LLC and 3,352 shares at $1,345.2428 through Stockbridge Fund, L.P..
  • Following these transactions, Robert Small indirectly owns 93,619 shares through Stockbridge Partners LLC, 484,632 shares through Stockbridge Fund, L.P., 60,246 shares through Family Trusts, and directly owns 15,539 shares.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock sales. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for directors and officers of publicly traded companies. It provides transparency to investors regarding the trading activities of company insiders.

Stakeholder Impact

  • The stock sale by a director could be perceived negatively by some shareholders, although it is a common occurrence.
  • The impact on other stakeholders is likely minimal.

Key Dates

DateDescription
03/13/2025Date of initial stock sale transactions.
03/14/2025Date of subsequent stock sale transactions.
03/17/2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.